MED · NYSE · Personal Products & Services

Medifast (MED)

Sells OPTAVIA nutrition plans through independent coaches and direct customer shipping.

$12.19
vs last close−0.07 (−0.57%)
Loading prices…

Medifast, Inc.MED
Consumer Discretionary

Offers one OPTAVIA segment of meal replacements, structured plans, and metabolic-health nutrition support, with revenue from U.S. product sales shipped directly to customers. Independent coaches drive customer support and social selling, while GLP-1 adoption and coach-network health shape demand.

Runs a single OPTAVIA segment built around Essential Fuelings, structured weight plans, OPTAVIA ACTIVE, OPTAVIA ASCEND, and GLP-1 Nutrition Support. Products ship directly to U.S. customers, while independent coaches provide habit support, community, and social selling without holding inventory.

Execution depends on keeping the coach network productive, refreshing meal-replacement and metabolic-health products, and translating physician-origin credibility into behavior-change support. The model pairs packaged nutrition with the Habits of Health system rather than operating clinics or pharmacies.

Demand is shaped by GLP-1 adoption, weight-loss programs, medications, surgery, apps, wearables, and regulatory scrutiny of coach claims. All revenue comes from U.S. product sales, and coach commissions are tied to those product sales.

Company facts

CEONicholas Johnson
ListedDec 20, 2002
ExchangeNYSE
HeadquartersBaltimore, MD
CountryUnited States
Employees380
CIK0000910329
ISINUS58470H1014

Market cap$136.3M
EPS (ttm)−$2.33
P/E (ttm)−5.26
ROE-12.7%
P/B0.6942
P/S0.4301
Dividend yieldDiv yield
Beta1.17vs XLY −0.15

Price target$17.00+38.7%Average of 12 analysts
ConsensusHold6 of 12 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Feb 19, 2026StephensTarget
Target:
Target: $12
Nov 5, 2024DA DavidsonUpgrade
Rating: UnderperformTarget: $17.50
Rating: NeutralTarget: $17

Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.35
Revenue estimate
$71.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.10−$0.11$0.23−$0.21−$0.55−$0.19−$0.28Pending
Estimate−$0.16−$0.25−$0.19−$0.01−$0.76−$0.55−$0.65−$0.35
Surprise+162.5%+56.0%+221.1%−2,000.0%+27.6%+65.5%+56.9%

RevenueReportedEstimate

Feb '25Apr '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$119.0M$115.7M$105.6M$89.4M$75.1M$76.0M$76.4MPending
Estimate$114.3M$116.4M$101.8M$71.4M$71.4M$69.2M$72.7M$71.3M
Surprise+4.2%−0.6%+3.7%+25.2%+5.2%+9.9%+5.1%
Estimate−$0.35
ReportedDue Nov 9, 2026
Estimate$71.3M
ReportedDue Nov 9, 2026
View details

Debt to equity14.10%
Current ratio486.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$140.2M$119.0M$115.7M$105.6M$89.4M$75.1M$76.0M$76.4M
Net income$1.1M$801.0K−$772.0K$2.5M−$2.3M−$18.1M−$2.1M−$3.1M
Net margin0.8%0.7%0.0%2.3%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$2.1M$709.0K−$1.3M−$1.1M−$4.1M−$7.8M−$1.1M−$4.3M
YoY growth−91.7%−91.8%Turned lossLoss narrowedTurned lossTurned lossLoss narrowedLoss widened

Balance sheet, Jun 30, 2026Cash & short-term investments $169.8M · Total debt $27.6M · Total assets $260.4M · Shareholders' equity $196.4M

Revenue
$76.4M
Operating income
−$4.3M
Net income
−$3.1M
View details

Dividend yield
Next ex-date
Annual dividend
Schedule

HistoryDividendAnnual yield

Dec '21Mar '22Jun '22Sep '22Dec '22Mar '23Jun '23Sep '23
Dividend$1.42$1.64$1.64$1.64$1.64$1.65$1.65$1.65
Annual yield2.62%3.45%3.24%5.40%5.74%6.63%7.30%8.20%
Ex-dateDec 20Mar 28Jun 27Sep 19Dec 19Mar 27Jun 26Sep 18
Payment dateFeb 8May 9Aug 8Nov 8Feb 7May 9Aug 8Nov 7
View details

Institutions77.44%8.66M shares
120 holders · as of Jun 30, 2026
Insiders11.25%1.26M shares
11 holders · as of Aug 28, 2026
Strategic holders6.40%715.9K shares
1 holder · as of May 15, 2026
Other4.91%548.1K shares
remainder

11.18M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Renaissance Technologies LLCInstitution
6.96%778,610as of Jun 30, 2026
Parsa KiaiInsiderdirector
6.68%747,079filed Aug 28, 2026
Citadel Securities GP LLCStrategic
6.40%715,910filed May 15, 2026
Steamboat Capital Partners, LLCInstitution
6.32%706,699as of Jun 30, 2026
Two Sigma Investments, LPInstitution
4.31%481,381as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 26, 2026Parsa Kiaidirector+43,150$12.26
Aug 24, 2026Parsa Kiaidirector+4,329$12.00
Aug 20, 2026Parsa Kiaidirector+43,150$11.60
Aug 19, 2026Parsa Kiaidirector+29,337$11.66
May 8, 2026Scott Schlackmandirector+2,500$12.65
View details

  • Herbalife

    Distributor-led nutrition peer with weight-management shakes

  • WeightWatchers

    Commercial weight-management platform with clinical support

  • Eli Lilly

    Zepbound-led GLP-1 substitute for structured weight loss

  • Novo Nordisk (ADR)

    Wegovy/Ozempic GLP-1 platform reshaping weight management

  • Hims & Hers Health

    Digital weight-loss platform with GLP-1 medication access

  • Simply Good Foods

    Atkins, Quest, and OWYN overlap with Fuelings and protein snacks

  • BellRing Brands

    Premier Protein and Dymatize contest protein-shake demand

Compare

CompanyPriceChange
Medifast$12.19−0.57%$136.3M0.4−27.6%
Herbalife$12.06+1.17%$1.24B7.74.50.2+5.4%
WeightWatchers$16.16−1.43%$163.9M0.2
Eli Lilly$1,169.22+0.37%$1.10T39.128.613.8+47.7%
Novo Nordisk (ADR)$39.44−0.92%$176.83B9.916.23.5+1.3%
Hims & Hers Health$31.42+7.04%$6.55B146.12.5+38.3%
Simply Good Foods$10.00+0.41%$880.9M6.00.6−6.3%
BellRing Brands$9.01+0.61%$1.04B6.37.50.4+4.2%
Median8.811.80.6+4.8%